Direct cleavage: Nanoparticles composed of MMP-9-cleavable materials, such as gelatin, are degraded in MMP-9-rich environments such as tumor microenvironments and vasculopathies, facilitating local drug release [139,141]. This evidence concerns the gene MMP9 and vascular disorder.